|
|
Volumn 3, Issue 8, 1997, Pages 324-
|
|
Antisense against protein kinase C-alpha mRNA makes sense for cancer therapy?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTISENSE OLIGODEOXYNUCLEOTIDE;
ANTISENSE OLIGONUCLEOTIDE;
ENZYME INHIBITOR;
ISIS 3521;
ISOENZYME;
MESSENGER RNA;
NUCLEOTIDE;
PRKCA PROTEIN, HUMAN;
PROTEIN KINASE C;
PROTEIN KINASE C ALPHA;
ANIMAL;
ARTICLE;
DRUG ANTAGONISM;
HUMAN;
METABOLISM;
NEOPLASM;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
STANDARD;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
ENZYME INHIBITORS;
HUMANS;
ISOENZYMES;
NEOPLASMS;
OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE;
OLIGONUCLEOTIDES, ANTISENSE;
PROTEIN KINASE C;
PROTEIN KINASE C-ALPHA;
RNA, MESSENGER;
THIONUCLEOTIDES;
|
|
EID: 0031205303
PISSN: 13574310
EISSN: None
Source Type: Journal
DOI: 10.1016/S1357-4310(97)83454-5 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
